Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Clinical trial NCT00095108 · COMPLETED

Trial details

NCT number: NCT00095108
Sponsor: ZymoGenetics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Kidney Neoplasms Metastases

Start date: 2004-05-01
Primary completion: 2007-01-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.